Concepedia

Fahrettin Haczeyni

FH

5

Publications

1.3K

Citations

5

H-Index

2015

Active since

Affiliations

University of Washington(Current)

Canberra Hospital

Australian National University

University of Washington Medical Center

Fahrettin Haczeyni is an author at University of Washington specializing in inflammation, pathology, and liver fibrosis.

Top concepts

Publications per year

2015–2017

5

Publications

5

NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice

Auvro R. Mridha, Alexander Wree, Avril A. B. Robertson et al. · Journal of Hepatology · 2017 · 1K citations · Full text

, , +14

The selective peroxisome proliferator–activated receptor‐delta agonist seladelpar reverses nonalcoholic steatohepatitis pathology by abrogating lipotoxicity in diabetic obese mice

Fahrettin Haczeyni, Vanessa Barn, Auvro R. Mridha et al. · Hepatology Communications · 2017 · 94 citations · Full text

TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival

Auvro R. Mridha, Fahrettin Haczeyni, Matthew M. Yeh et al. · Clinical Science · 2017 · 82 citations

Exercise improves adipose function and inflammation and ameliorates fatty liver disease in obese diabetic mice

Fahrettin Haczeyni, Vanessa Barn, Auvro R. Mridha et al. · Obesity · 2015 · 47 citations · Full text

Obeticholic acid improves adipose morphometry and inflammation and reduces steatosis in dietary but not metabolic obesity in mice

Fahrettin Haczeyni, Laurence Poekes, Auvro R. Mridha et al. · Obesity · 2016 · 46 citations · Full text

Rows per page

1–5 of 5